Introduction: Cerebral venous and sinus thrombosis (CVST) may lead to cerebral edema and increased intracranial pressure; besides, ischemic or hemorrhagic lesions may develop. Intracerebral hemorrhages occur in approximately one-third of CVST patients. We assessed and compared the findings of the cerebral hemorrhage (CH) group and the CVST group. Materials and Methods: In the VENOST study, medical records of 1,193 patients with CVST, aged over 18 years, were obtained from 35 national stroke centers. Demographic characteristics, clinical symptoms, signs at the admission, radiological findings, etiologic factors, acute and maintenance treatment, and outcome results were reported. The number of involved sinuses or veins, localizations of thrombus, and lesions on CT and MRI scans were recorded. Results: CH was detected in the brain imaging of 241 (21.1%) patients, as hemorrhagic infarction in 198 patients and intracerebral hemorrhage in 43 patients. Gynecologic causes comprised the largest percentage (41.7%) of etiology and risk factors in the CVST group. In the CH group, headache associated with other neurological symptoms was more frequent. These neurological symptoms were epileptic seizures (46.9%), nausea and/or vomiting (36.5%), altered consciousness (36.5%), and focal neurological deficits (33.6%). mRS was ≥3 in 23.1% of the patients in the CH group. Discussion and Conclusion: CVST, an important cause of stroke in the young, should be monitored closely if the patients have additional symptoms of headache, multiple sinus involvement, and CH. Older age and parenchymal lesion, either hemorrhagic infarction or intracerebral hemorrhage, imply poor outcome.

1.
Coutinho
JM
,
Zuurbier
SM
,
Aramideh
M
,
Stam
J
.
The incidence of cerebral venous thrombosis: a cross-sectional study
.
Stroke
.
2012
;
43
(
12
):
3375
7
. .
2.
Duman
T
,
Uluduz
D
,
Midi
I
,
Bektas
H
,
Kablan
Y
,
Goksel
BK
, et al.
A multicenter study of 1144 patients with cerebral venous thrombosis: the VENOST study
.
J Stroke Cerebrovasc Dis
.
2017 Aug
;
26
(
8
):
1848
57
. .
3.
Zuurbier
SM
,
Coutinho
JM
.
Cerebral venous thrombosis
.
Adv Exp Med Biol
.
2017
;
906
:
183
93
. .
submitted for publication
4.
Girot
M
,
Ferro
JM
,
Canhão
P
,
Stam
J
,
Bousser
MG
,
Barinagarrementeria
F
, et al.
Predictors of outcome in patients with cerebral venous thrombosis and intracerebral hemorrhage
.
Stroke
.
2007
;
38
(
2
):
337
42
.
5.
Ferro
JM
,
Canhão
P
,
Stam
J
,
Bousser
MG
,
Barinagarrementeria
F
;
ISCVT Investigators
.
Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT)
.
Stroke
.
2004
;
35
(
3
):
664
70
. .
6.
Ferro
JM
,
Correia
M
,
Pontes
C
,
Baptista
MV
,
Pita
F
;
Cerebral Venous Thrombosis Portuguese Collaborative Study Group (Venoport)
.
Cerebral vein and dural sinus thrombosis in Portugal: 1980–1998
.
Cerebrovasc Dis
.
2001
;
11
(
3
):
177
82
.
7.
Kumral
E
,
Polat
F
,
Uzunköprü
C
,
Callı
C
,
Kitiş
Ö
.
The clinical spectrum of intracerebral hematoma, hemorrhagic infarct, non-hemorrhagic infarct, and non-lesional venous stroke in patients with cerebral sinus-venous thrombosis
.
Eur J Neurol
.
2012
;
19
(
4
):
537
43
. .
8.
Saposnik
G
,
Barinagarrementeria
F
,
Brown
RD
 Jr
,
Bushnell
CD
,
Cucchiara
B
,
Cushman
M
, et al.
American Heart Association Stroke Council and the Council on Epidemiology and Prevention. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association
.
Stroke
.
2011
;
42
(
4
):
1158
92
.
9.
Stam
J
.
Thrombosis of the cerebral veins and sinuses
.
N Engl J Med
.
2005 Apr 28
;
352
(
17
):
1791
8
. .
10.
Wasay
M
,
Bakshi
R
,
Bobustuc
G
,
Kojan
S
,
Sheikh
Z
,
Dai
A
, et al.
Cerebral venous thrombosis: analysis of a multicenter cohort from the United States
.
J Stroke Cerebrovasc Dis
.
2008
;
17
(
2
):
49
54
. .
11.
Coutinho
JM
,
Ferro
JM
,
Canhão
P
,
Barinagarrementeria
F
,
Cantú
C
,
Bousser
MG
, et al.
Cerebral venous and sinus thrombosis in women
.
Stroke
.
2009
;
40
(
7
):
2356
61
. .
12.
Narayan
D
,
Kaul
S
,
Ravishankar
K
,
Suryaprabha
T
,
Bandaru
VC
,
Mridula
KR
, et al.
Risk factors, clinical profile, and long-term outcome of 428 patients of cerebral sinus venous thrombosis: insights from Nizam’s Institute Venous Stroke Registry, Hyderabad (India)
.
Neurol India
.
2012 Mar–Apr
;
60
(
2
):
154
9
.
13.
Sidhom
Y
,
Mansour
M
,
Messelmani
M
,
Derbali
H
,
Fekih-Mrissa
N
,
Zaouali
J
, et al.
Cerebral venous thrombosis: clinical features, risk factors, and long-term outcome in a Tunisian cohort
.
J Stroke Cerebrovasc Dis
.
2014
;
23
(
6
):
1291
5
. .
14.
Wang
JW
,
Li
JP
,
Song
YL
,
Tan
K
,
Wang
Y
,
Li
T
, et al.
Clinical characteristics of cerebral venous sinus thrombosis
.
Neurosciences
.
2015
;
20
(
3
):
292
5
. .
15.
Kato
Y
,
Takeda
H
,
Furuya
D
,
Nagoya
H
,
Deguchi
I
,
Fukuoka
T
, et al.
Subarachnoid hemorrhage as the initial presentation of cerebral venous thrombosis
.
Intern Med
.
2010
;
49
(
5
):
467
70
. .
16.
Uluduz
D
,
Midi
I
,
Duman
T
,
Colakoglu
S
,
Tüfekci
A
,
Bakar
M
, et al.
Behçet’s disease as a causative factor of cerebral venous sinus thrombosis: subgroup analysis of data from the VENOST study
.
Rheumatology
.
2019 Apr 1
;
58
(
4
):
600
8
.
17.
Ferro
JM
,
Canhão
P
,
Bousser
MG
,
Stam
J
,
Barinagarrementeria
F
,
ISCVT Investigators
.
Early seizures in cerebral vein and dural sinus thrombosis: risk factors and role of antiepileptics
.
Stroke
.
2008
;
39
(
4
):
1152
8
. .
18.
Koopman
K
,
Uyttenboogaart
M
,
Vroomen
PC
,
van der Meer
J
,
De Keyser
J
,
Luijckx
GJ
.
Long-term sequelae after cerebral venous thrombosis in functionally independent patients
.
J Stroke Cerebrovasc Dis
.
2009
;
18
(
3
):
198
202
. .
19.
de Bruijn
SF
,
de Haan
RJ
,
Stam
J
.
Clinical features and prognostic factors of cerebral venous sinus thrombosis in a prospective series of 59 patients. For The Cerebral Venous Sinus Thrombosis Study Group
.
J Neurol Neurosurg Psychiatry
.
2001 Jan
;
70
(
1
):
105
8
. .
20.
Ferro
JM
,
Canhão
P
,
Bousser
MG
,
Stam
J
,
Barinagarrementeria
F
,
Stolz
E
.
Cerebral venous thrombosis with nonhemorrhagic lesions: clinical correlates and prognosis
.
Cerebrovasc Dis
.
2010
;
29
(
5
):
440
5
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.